Dr. Mi Chang, MD

Dr. Chang practices at Kaiser Permanente South Bay Medical Center in Harbor City, California, part of Kaiser Permanente.

Dr. Chang's NPI, 1174675557, was assigned on January 17, 2007. Dr. Chang graduated from Saint Louis University School Of Medicine in 2001. Dr. Chang holds California license A81161.

Dr. Chang's primary practice is Kaiser Permanente South Bay Medical Center, at 25825 South Vermont Avenue, Harbor City, CA 90710 in Los Angeles County. The practice phone is (310) 325-5111.

Dr. Chang's primary practice is Kaiser Permanente South Bay Medical Center in Harbor City, California, part of Kaiser Permanente. The medical group on file is Southern California Permanente Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chang practices. Vendor and product names are available with a free account.

Nephrology is Dr. Chang's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Chang is board certified in nephrology by the American Board of Internal Medicine. Dr. Chang is licensed in California.

CMS data shows 34 Medicare services from Dr. Chang across 1 procedure code in 2024, for 29 Medicare patients. Medicare paid $2,201 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 29 Medicare patients who saw Dr. Chang in 2024. The largest group is under 65, with 12 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 52% are also on Medicaid. Their average risk score is 5.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chang's median patient age at 65, with 52% women.

In 2024, Dr. Chang wrote 1,087 Medicare Part D claims for 225 patients. 94% of them were for generic drugs. CMS names the drug for 895 of them, across 20 drugs with 11 or more claims each, at $90,969 in total drug cost. In 2023, CMS named 935 claims across 21 drugs.

Dr. Chang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Chang, published from 2010 to 2019. 2014 was the busiest year, with 6. The most frequent topics are Ligands, Nuclear Receptor Subfamily 1, Group F, Member 3 and Protein Binding. Dr. Chang has published most often in Nat Commun. Dr. Chang's most frequent co-authors are Pushkar Chand, MD, Tanja Andrea Gruber, MD and Tuan Le, MD.

CMS Open Payments shows 2 general payments to Dr. Chang from 2 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $106.

Dmand AI lists 1 award for Dr. Chang, most recently CMS Stage 1 2012 in 2011.

Dr. Chang graduated from Saint Louis University School Of Medicine in 2001.

Dr. Chang is in network with 3 carriers, including Blue Cross Blue Shield of Massachusetts, HCSC and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.